Early Evaluation of Tumoral Response to Antiangiogenic Therapy by Arterial Spin Labeling Perfusion Magnetic Resonance Imaging and Susceptibility Weighted Imaging in a Patient With Recurrent Glioblastoma Receiving Bevacizumab - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Journal of Clinical Oncology Année : 2011

Early Evaluation of Tumoral Response to Antiangiogenic Therapy by Arterial Spin Labeling Perfusion Magnetic Resonance Imaging and Susceptibility Weighted Imaging in a Patient With Recurrent Glioblastoma Receiving Bevacizumab

Domaines

Imagerie

Virginie Callot  : Connectez-vous pour contacter le contributeur

https://amu.hal.science/hal-02372640

Soumis le : mercredi 20 novembre 2019-15:09:31

Dernière modification le : jeudi 2 novembre 2023-16:14:25

Fichier non déposé

Dates et versions

hal-02372640 , version 1 (20-11-2019)

Identifiants

Citer

Slim Fellah, Nadine Girard, O. Chinot, Patrick J Cozzone, Virginie Callot. Early Evaluation of Tumoral Response to Antiangiogenic Therapy by Arterial Spin Labeling Perfusion Magnetic Resonance Imaging and Susceptibility Weighted Imaging in a Patient With Recurrent Glioblastoma Receiving Bevacizumab. Journal of Clinical Oncology, 2011, 29 (11), pp.e308-e311. ⟨10.1200/JCO.2010.32.6082⟩. ⟨hal-02372640⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS UNIV-AMU CRMBM
18 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More